102 related articles for article (PubMed ID: 7943778)
1. Glutamatergic antagonism: effects on lidocaine-induced seizures in the rat.
McFarlane C; Warner DS; Dexter F; Todd MM
Anesth Analg; 1994 Oct; 79(4):701-5. PubMed ID: 7943778
[TBL] [Abstract][Full Text] [Related]
2. AMPA receptor competitive antagonism reduces halothane MAC in rats.
McFarlane C; Warner DS; Todd MM; Nordholm L
Anesthesiology; 1992 Dec; 77(6):1165-70. PubMed ID: 1334638
[TBL] [Abstract][Full Text] [Related]
3. Interactions between NMDA and AMPA glutamate receptor antagonists during halothane anesthesia in the rat.
McFarlane C; Warner DS; Dexter F
Neuropharmacology; 1995 Jun; 34(6):659-63. PubMed ID: 7566502
[TBL] [Abstract][Full Text] [Related]
4. Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia.
Minger SL; Geddes JW; Holtz ML; Craddock SD; Whiteheart SW; Siman RG; Pettigrew LC
Brain Res; 1998 Nov; 810(1-2):181-99. PubMed ID: 9813316
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system toxicity of local anesthetic mixtures in the rat.
Spiegel DA; Dexter F; Warner DS; Baker MT; Todd MM
Anesth Analg; 1992 Dec; 75(6):922-8. PubMed ID: 1443711
[TBL] [Abstract][Full Text] [Related]
6. Glycine receptor antagonism. Effects of ACEA-1021 on the minimum alveolar concentration for halothane in the rat.
McFarlane C; Warner DS; Nader A; Dexter F
Anesthesiology; 1995 Apr; 82(4):963-8. PubMed ID: 7717569
[TBL] [Abstract][Full Text] [Related]
7. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
Nellgård B; Wieloch T
Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
[TBL] [Abstract][Full Text] [Related]
8. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia.
Nellgård B; Wieloch T
Exp Brain Res; 1992; 92(2):259-66. PubMed ID: 1362958
[TBL] [Abstract][Full Text] [Related]
9. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Hao JX; Xu XJ
Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
[TBL] [Abstract][Full Text] [Related]
10. Propofol prevents or elevates the threshold for lidocaine-induced seizures in rats.
Hartung J; Ying H; Weinberger J; Cottrell JE
J Neurosurg Anesthesiol; 1994 Oct; 6(4):254-9. PubMed ID: 8000199
[TBL] [Abstract][Full Text] [Related]
11. Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.
Farfel GM; Seiden LS
J Pharmacol Exp Ther; 1995 Feb; 272(2):860-7. PubMed ID: 7531765
[TBL] [Abstract][Full Text] [Related]
12. Propofol sedation produces dose-dependent suppression of lidocaine-induced seizures in rats.
Lee VC; Moscicki JC; DiFazio CA
Anesth Analg; 1998 Mar; 86(3):652-7. PubMed ID: 9495432
[TBL] [Abstract][Full Text] [Related]
13. Ionotropic glutamate receptor antagonists inhibit the proliferation of granule cell precursors in the adult brain after seizures induced by pentylenetrazol.
Jiang W; Wolfe K; Xiao L; Zhang ZJ; Huang YG; Zhang X
Brain Res; 2004 Sep; 1020(1-2):154-60. PubMed ID: 15312797
[TBL] [Abstract][Full Text] [Related]
14. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
[TBL] [Abstract][Full Text] [Related]
15. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
16. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of non-NMDA receptors inhibits handling-induced, strychnine-potentiated convulsions.
McAllister KH
Eur J Pharmacol; 1993 Feb; 231(2):309-12. PubMed ID: 8384115
[TBL] [Abstract][Full Text] [Related]
18. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons.
Wang T; French ED
Synapse; 1993 Mar; 13(3):270-7. PubMed ID: 7684531
[TBL] [Abstract][Full Text] [Related]
20. The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation.
Brunson KL; Schultz L; Baram TZ
Brain Res Dev Brain Res; 1998 Nov; 111(1):119-28. PubMed ID: 9804917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
